MedPath

重庆健能医药开发有限公司

Ownership
-
Established
2003-10-31
Employees
-
Market Cap
-
Website
www.jewellandpharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

8

NMPA:8

Drug Approvals

Lactulose Oral Solution

Product Name
乳果糖口服溶液
Approval Number
国药准字H20253369
Approval Date
Feb 11, 2025
NMPA

Lactulose Oral Solution

Product Name
乳果糖口服溶液
Approval Number
国药准字H20253370
Approval Date
Feb 11, 2025
NMPA

Magnesium Sulfate, Sodium Sulfate and Potassium Sulfate Concentrate Oral Solution

Product Name
硫酸镁钠钾口服用浓溶液
Approval Number
国药准字H20249699
Approval Date
Dec 6, 2024
NMPA

Sodium Valproate Oral Solution

Product Name
丙戊酸钠口服溶液
Approval Number
国药准字H20244966
Approval Date
Sep 26, 2024
NMPA

Sodium Valproate Oral Solution

Product Name
丙戊酸钠口服溶液
Approval Number
国药准字H20244965
Approval Date
Sep 26, 2024
NMPA

Polyethylene Glycol Electrolytes Powder(III)

Product Name
复方聚乙二醇电解质散(Ⅲ)
Approval Number
国药准字H20244333
Approval Date
Jun 28, 2024
NMPA

Ambroxol Hydrochloride Oral Solution

Product Name
盐酸氨溴索口服溶液
Approval Number
国药准字H20234664
Approval Date
Dec 19, 2023
NMPA

Ambroxol Hydrochloride Oral Solution

Product Name
盐酸氨溴索口服溶液
Approval Number
国药准字H20233009
Approval Date
Jan 3, 2023
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.